SS
LUMO

Steve Schonfeld’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Steve Schonfeld’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,722
Closed -$177K – 1014
2018
Q1 		$177K Buy
+2,722
New +$193K 0.01% 693
2017
Q2 		– Sell
-1,615
Closed -$351K – 804
2017
Q1 		$351K Buy
+1,615
New +$231K 0.04% 438

Other funds holding LUMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Steve Schonfeld's LUMO Position: Q2 2018 in Review

Steve Schonfeld sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 2,722 shares — an estimated $177K sold.

Steve Schonfeld first reported a position in LUMO in Q1 2017 and held it in 2 quarters. The position peaked at $351K in Q1 2017. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

  • Steve Schonfeld reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Steve Schonfeld sold 2,722 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $177K.
  • Steve Schonfeld first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Steve Schonfeld's Lumos Pharma, Inc. Common Stock position peaked at $351K in Q1 2017.
  • 106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.